Results 121 to 130 of about 577,500 (293)
Структурні зміни тригліцеридів плазми крові у хворих на прогресуючу стенокардію та їх медикаментозна корекція [PDF]
Дослiджено жирнокислотний спектр триглiцеридiв плазми кровi при нестабiльнiй стенокардiї з метою пiдвищення ефективностi лiкування шляхом застосування препаратiв групи статинiв.
Артемчук, О.О.+3 more
core
Abstract Aims To evaluate the efficacy and safety of adding lobeglitazone to a triple therapy regimen in Korean patients with type 2 diabetes whose blood glucose levels were inadequately controlled despite dual therapy with metformin and sitagliptin.
Eun‐Gyoung Hong+18 more
wiley +1 more source
Intensive versus standard dose statin therapy: the costs and benefits for patients with acute coronary syndrome [PDF]
Introduction: Recent NICE guidance in England and Wales states that statin therapy for secondary CVD should "usually be initiated with a drug with a low acquisition cost (taking into account required daily dose and product price per dose)".
Ara, R.+3 more
core +3 more sources
Abstract Aims Effective weight management pharmacotherapies are a new alternative to bariatric surgery or health behaviour intervention (HBI) alone. Comparative cost‐effectiveness evaluations can guide decision‐making. We aimed to evaluate the cost‐effectiveness of sleeve gastrectomy (SG), Roux‐en‐Y gastric bypass (RYGB), semaglutide, tirzepatide, and ...
Nisha Gupta+5 more
wiley +1 more source
In a population of patients with stable CAD, circulating levels of PCSK9 are independently associated with the progression of adverse coronary plaque phenotypes, as assessed by serial coronary computed tomography angiography. At RNA‐seq analysis of whole blood, PCSK9 was linked to the expression of genes involved in the innate‐immune response.
Rosetta Ragusa+7 more
wiley +1 more source
Despite universal healthcare in Switzerland, disparities in post‐acute coronary syndrome (ACS) care persist across educational levels. In a cohort of 6040 patients, those with the lowest education had more cardiovascular risk factors and were less likely to attend cardiac rehabilitation or receive cardiology follow‐up.
Maëlle Achard+14 more
wiley +1 more source
Cardiovascular Biomarkers in Nocturnal Hemodialysis and Their Association With Physical Performance
ABSTRACT Introduction The cardiovascular biomarkers troponin T, N‐terminal pro‐B‐type natriuretic peptide, and fibroblast growth factor 23 are elevated in hemodialysis patients and associated with an increased cardiovascular mortality risk. Nocturnal hemodialysis improves the fluid status in hemodialysis patients.
Manouk Dam+6 more
wiley +1 more source
WISDOM: history and early demise - was it inevitable?
In 1989, the UK Medical Research Council (MRC) agreed that, if feasible, a randomized controlled trial to assess the long-term risks and benefits of hormone replacement therapy (HRT) was a priority.
Darbyshire, J, Meade, T, Vickers, M
core +1 more source
The introduction of intravenously administered nitrate formulations such as intravenous nitroglycerin and intravenous isosorbide dinitrate has markedly improved the conservative therapy of unstable angina. These formulations, originally used only in coronary care units, are now used in general medical wards and emergencies rooms, without hemodynamic ...
Marija Weiss, Adam Schneeweiss
openaire +2 more sources
E. Antman+9 more
semanticscholar +1 more source